Cardium Therapeutics, Inc. (CXM) Announces Upcoming Presentation at 2012 Noble Financial Life Sciences Investor Conference

Today before the opening bell, Cardium Therapeutics announced that Chairman & CEO Christopher J. Reinhard will be presenting at the BioX Noble Financial Life Sciences Exposition being held at the University of Connecticut, Stamford Campus on September 24 – 25, 2012.

A video webcast of the presentation, along with a copy of the slide deck, will be available shortly after the conference on Thursday, September 27, 2012, at http://phx.corporate-ir.net/phoenix.zhtml?c=77949&p=irol-calendar, as well as through the Noble Financial website at www.noblefcm.com. Microsoft SilverLight viewer will need to be installed to participate. The investor presentation is now available at http://phx.corporate-ir.net/phoenix.zhtml?c=77949&p=irol-presentations.

Cardium Therapeutics is a health sciences and regenerative medicine company focused on acquiring and strategically developing new and innovative products and businesses to address significant unmet medical needs. Comprised of large-market opportunities with definable pathways to commercialization, partnering, and other economic monetizations, Cardium’s current portfolio includes the Tissue Repair Company, Cardium Biologics, and the company’s in-house MedPodium Health Sciences healthy lifestyle product platform.

To learn more about the company, visit www.cardiumthx.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html